QUICK LINKS
GTAM8 Marker Antibody (B43.8) is a mouse monoclonal IgG1 antibody that detects GTAM8 of human origin by western blotting (WB), immunofluorescence (IF), and immunohistochemistry. Anti-GTAM8 antibody (B43.8) is available in a non-conjugated form, providing flexibility for various experimental needs. GTAM8, or gastrointestinal tumor-associated marker 8, plays a crucial role in identifying gastric carcinoma, a cancer that can arise in any part of the stomach and metastasize to other organs such as the esophagus and small intestine. GTAM8 expression occurs in various tissues, including pancreas, lung, colon, ovary, prostate, and gastric carcinomas, making GTAM8 a valuable biomarker for malignancy. Understanding GTAM8 structure is essential, as this glycoprotein undergoes post-translational modifications, including glycosylation, which can influence stability, localization, and protein interactions. These modifications affect GTAM8 function in tumor biology by impacting cell signaling pathways and immune response to cancer cells. Accurate detection of GTAM8 using GTAM8 monoclonal antibody (B43.8) can aid in early diagnosis of gastric carcinoma and help differentiate between benign and malignant conditions, ultimately contributing to more effective treatment strategies.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
GTAM8 Marker Antibody (B43.8) | sc-59195 | 500 µl supernatant | $316.00 |